Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give written consent to participate
- Men and women aged 18 years or older
- People who have been diagnosed with Type 2 diabetes for between 0 and 6 years, confirmed by at least 2 diagnostic test results (HbA1c and/or blood glucose tests)
- People managing diabetes through diet alone whose recent HbA1c blood sugar level was at or above a certain threshold (48 mmol/mol) within the last 12 months
- People taking diabetes tablets or GLP-1 medications whose recent HbA1c blood sugar level was at or above a certain threshold (43 mmol/mol)
- People with a Body Mass Index (BMI) above 27 kg/m²
- People whose weight has been relatively stable over the last 6 months, with or without weight-loss medication
- People who report that they want to lose weight
- People who own a smartphone
Who may not be able to join:
- People who are currently using insulin
- People whose weight has changed by more than 5% in the last 6 months, or who have recently started taking weight-loss medications (including orlistat, bupropion-naltrexone, phentermine-topiramate, semaglutide, tirzepatide, liraglutide, or dulaglutide)
- People whose most recent HbA1c blood sugar reading was at or above 108 mmol/mol
- People with significantly reduced kidney function (eGFR below 30 ml/min/1.73m²)
- People with a known cancer diagnosis
- People who have had a heart attack within the last 6 months
- People with severe heart failure (classified as NYHA Grade 3 or equivalent)
- People who are pregnant, considering becoming pregnant, or exclusively breastfeeding
- People with a history of substance abuse involving drugs or alcohol
- People who have been diagnosed with an eating disorder, or whose responses to a screening questionnaire suggest a possible eating disorder
- People with learning difficulties, or those who are unable to understand, speak, or read Norwegian or English
- People who have previously been hospitalised for depression or who are currently taking antipsychotic medication
- People who are currently taking part in another clinical research trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne-Marie Aas, PhD, Oslo University Hospital and University of Oslo
Phone: +47 47302912
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in body weight from baseline (weight loss)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.